Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility of Cetuximab with Concomitant Radio-chemotherapy in NSCLC
NCT00985855Phase 2Completed
- Sponsor
- Institut de Cancérologie Lucien Neuwirth
- Start
- Sep 2009
- Primary completion
- Aug 2011
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab in non-small cell lung cancer (NSCLC), sponsored by Institut de Cancérologie Lucien Neuwirth. Started Sep 2009; status: completed.
02
Drugs
cetuximab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00985855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00985855.